• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

Dolores “Dee” Holden Norris (1946–2025), Ted’s wife, championed the award and the standards of clinical excellence it represents. In December 2025, the International Alliance paid tribute to Dee — nurse, advocate, co-founder of the Alliance, and a driving force behind the multidisciplinary model of ALS/MND care.

Working alongside Ted, she helped transform how ALS/MND care is delivered worldwide. At a time when patients were often offered little more than prognosis, they envisioned something fundamentally different: coordinated, team-based care grounded in clinical excellence and compassion. Their work helped establish the global standard for multidisciplinary ALS/MND clinics and laid the foundation for the collaborative international community that exists today.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period will open on July 1. 

Primary Sidebar

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Ian Gale, Australia

    Ian Gale, Australia

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Hollister

    Hollister
    hollister

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Lombana, Spain

    Lombana, Spain

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Sally Pauls, USA

    Sally Pauls, USA

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Liam Dwyer, England

    Liam Dwyer, England

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Susan Keldani, USA

    Susan Keldani, USA

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Richard Clark, New Zealand

    Richard Clark, New Zealand

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Jean Waters, UK

    Jean Waters, UK

  • Purningam Jacob, India

    Purningam Jacob, India

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Art Eggert, USA

    Art Eggert, USA

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Mike Cels, Canada

    Mike Cels, Canada

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

Learn more about the March of Faces

Footer

Subscribe to our Bi-monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login